| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |